Enavatuzumab, CAS [[1062149-33-0]]

Produktübersicht

• Artikelname: Enavatuzumab, CAS [[1062149-33-0]]
• Artikelnummer: TGM-T76865
• Hersteller Artikelnummer: T76865
• Alternativnummer: TGM-T76865-1MG,TGM-T76865-5MG,TGM-T76865-10MG,TGM-T76865-25MG,TGM-T76865-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: Anti-TNFRSF12A/TWEAKR/CD266 Reference Antibody , PDL192 , ABT361 , ABT-361 , PDL-192

Produktbeschreibung

Enavatuzumab (PDL192) is a humanized monoclonal antibody targeting the TWEAK receptor (TWEAKR), with anti-tumor activity. It induces tumor growth inhibition by recruiting and activating myeloid effectors to kill tumor cells. It is used in late-stage solid tumor research.

Produkteigenschaften

• Reinheit: >95%
• CAS Nummer: [1062149-33-0]
• Target-Kategorie: TNF